Programme Introduction
About this programme
💊 Pharmacy Practice
✅ Regulatory & Clinical
📋 Case-Based Learning
The Central Drugs Standard Control Organisation (CDSCO) is India’s national regulatory authority for pharmaceuticals, overseeing the approval pathway that new drugs must pass through before reaching Indian patients.
Understanding this pathway means following a drug from regulatory submission through clinical trial approval to ongoing safety review, since each stage has distinct requirements and regulatory touchpoints.
TerraLeap’s CDSCO Drug Approval Process course is designed for pharmacy and regulatory affairs teams, covering regulatory submission, trial approval, and safety review.
The course covers core CDSCO submission requirements, the clinical trial approval pathway in India, and post-approval safety review and pharmacovigilance obligations.
Clinical and regulatory expertise — built for real pharmacy practice.
Programme Scope
What this programme covers
This course covers submission, trial approval, and safety review for the CDSCO drug approval process.
📋
Regulatory submission
Core CDSCO submission requirements for new drug applications.
🔬
Clinical trial approval
The pathway for clinical trial approval in India.
⚠️
Safety review
Post-approval safety review and pharmacovigilance obligations.
📊
Documentation standards
Structuring documentation to meet CDSCO expectations.
🏥
Stakeholder roles
Understanding CDSCO, ethics committees, and sponsor responsibilities.
🌍
International alignment
How CDSCO processes relate to broader international regulatory practice.
👥
Cross-functional collaboration
Working across regulatory, clinical, and quality functions.
Learning Objectives
What you will achieve
After completing this course, learners will be able to describe the CDSCO drug approval pathway from submission through safety review.
Each objective targets a specific stage of the CDSCO approval pathway.
01
Describe core CDSCO submission requirements for new drug applications
02
Describe the pathway for clinical trial approval in India
03
Describe post-approval safety review and pharmacovigilance obligations
04
Structure documentation to meet CDSCO expectations
05
Understand the respective roles of CDSCO, ethics committees, and sponsors
06
Relate CDSCO processes to broader international regulatory practice
07
Collaborate effectively across regulatory, clinical, and quality functions
Target Audience
Who can enroll
This course is designed for pharmacy and regulatory affairs teams working with India’s drug approval process.
Whether you are new to Indian pharmaceutical regulation or building on existing experience, this course strengthens practical CDSCO process knowledge.
📚
Pharmacy professionals building foundational regulatory knowledge
💼
Regulatory affairs teams working with CDSCO submissions
🏢
Life-sciences professionals supporting Indian drug approvals
🎓
Students exploring pharmaceutical regulatory affairs
📋
Quality teams supporting regulatory submission processes
Programme Certification
Your certificate
Upon successful completion of this programme, you will receive a digital certificate recognising your achievement and the competencies you have acquired throughout the course.
Certificates for TerraLeap programmes are issued and signed by authorised TerraLeap representatives. For programmes delivered in collaboration with universities, institutions, or industry organisations, certificates are jointly issued and co-signed by authorised representatives of both TerraLeap and the respective partner.
Each certificate carries a unique Certificate ID and QR code to enable instant authenticity verification — making it easy to share with employers, licensing bodies, or professional networks as evidence of your learning.
Note on scope. TerraLeap certificates confirm successful completion of the respective programme and recognise your professional development and continuing education. They do not constitute a professional licence or regulatory authorisation unless explicitly stated in the programme description.
TERRALEAP
Certificate ID
TL-2026-AB7K3X9P
Official
Seal
Certificate of Completion
Successfully Completed
Awarded in recognition of academic achievement
This is to certify that
XXXXX
has successfully completed the prescribed course of study, demonstrating commitment, diligence, and proficiency in
CDSCO Drug Approval Process
and is hereby awarded this certificate by TerraLeap, recognising the candidate's mastery of the syllabus and successful evaluation.